Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Isotretinoin topical - LEO Pharma

Next Previous
Search
Drug Profile

Isotretinoin topical - LEO Pharma

Alternative Names: PAT-001; TMB-001; Topical isotretinoin - Timber Pharmaceuticals

Latest Information Update: 26 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Patagonia Pharmaceuticals
  • Developer Timber Pharmaceuticals
  • Class Anti-inflammatories; Antiacnes; Antineoplastics; Keratolytics; Retinoids; Skin disorder therapies; Small molecules
  • Mechanism of Action Ornithine decarboxylase inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Congenital ichthyosiform erythroderma; X linked Ichthyosis
  • New Molecular Entity No

Highest Development Phases

  • Phase III Congenital ichthyosiform erythroderma; X linked Ichthyosis

Most Recent Events

  • 21 Aug 2024 Efficacy data from the phase III ASCEND trial in X-linked-Ichthyosis released by LEO Pharma
  • 10 Mar 2024 Efficacy, adverse event and pharmacokinetics data from a phase III ASCEND trial in X-linked-Ichthyosis released by Timber Pharmaceuticals
  • 08 Mar 2024 Pharmacokinetics data from the phase III ASCEND trial in X-linked-Ichthyosis presented at the American Academy of Dermatology annual Meeting 2024 (AAD-2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top